文献速递肿瘤 PET/CT

新诊断多发性骨髓瘤患者68Ga-Pentixafor PET/CT检出髓外喉部受累

Detection of Extramedullary Laryngeal Involvement on 68 Ga-Pentixafor PET/CT in a Newly Diagnosed Patient of Multiple Myeloma.
PubMed 文献 · Clin Nucl Med · 2025-04-23

一名40岁新诊断多发性骨髓瘤男性患者同时接受68Ga-Pentixafor与18F-FDG PET/CT检查,两种模态均显示弥漫性骨髓受累、局灶性病变及髓外喉部受累。68Ga-Pentixafor PET/CT在多发性骨髓瘤中的应用日益增多,诊断性能与18F-FDG PET/CT相似。本文报道一例基线时两种PET/CT均显示髓外喉部受累的罕见病例。

要点

  • 新诊断多发性骨髓瘤患者基线时68Ga-Pentixafor与18F-FDG PET/CT均检出髓外喉部受累。
  • 68Ga-Pentixafor PET/CT在多发性骨髓瘤中的诊断性能与18F-FDG PET/CT相似。
  • 髓外喉部受累在多发性骨髓瘤基线时属罕见表现。

核心结论

  • 本文报道一例新诊断多发性骨髓瘤患者基线时68Ga-Pentixafor与18F-FDG PET/CT均检出髓外喉部受累的罕见病例。

研究设计与样本

  • 个案报道:一名40岁新诊断多发性骨髓瘤男性患者接受68Ga-Pentixafor与18F-FDG PET/CT检查。

主要发现

  • 两种模态均显示弥漫性骨髓受累、局灶性病变及髓外喉部受累。
  • 68Ga-Pentixafor PET/CT在多发性骨髓瘤中的应用日益增多,诊断性能与18F-FDG PET/CT相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 40-year-old man with newly diagnosed multiple myeloma underwent both 68 Ga-Pentixafor and 18 F-FDG PET/CT. Extramedullary laryngeal involvement was noted on both modalities in addition to diffuse marrow involvement and focal lesions. 68 Ga-Pentixafor PET/CT is increasingly used in multiple myeloma and demonstrates similar diagnostic performance as 18 F-FDG PET/CT. We present a rare case of extramedullary laryngeal involvement at baseline on both 68 Ga-Pentixafor and 18 F-FDG PET/CT.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kumar S, Kaur H, Watts A, et al. Detection of Extramedullary Laryngeal Involvement on 68 Ga-Pentixafor PET/CT in a Newly Diagnosed Patient of Multiple Myeloma. Clin Nucl Med. 2025. PMID: 40263762. doi:10.1097/RLU.0000000000005822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。